INS and ischemic stroke: In short, AKT is an essential pathway for insulin to exert its physiological effects, and although clinical trials of intranasal insulin administration for ischemic stroke need to be supplemented, the evidence for intranasal insulin administration in protecting neurological function is sufficient.